ECOG-ACRIN Cancer Research Group   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Philadelphia PA United States (2012)

Organization Overview

First Clinical Trial
2012
NCT00002525
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ECOG-ACRIN Cancer Research Group